|
Volumn 106, Issue 5, 2002, Pages 592-598
|
Assessment of myocardial inflammation produced by experimental coronary occlusion and reperfusion with 99mTc-RP517, a new leukotriene B4 receptor antagonist that preferentially labels neutrophils in vivo
|
Author keywords
Imaging; Inflammation; Myocardium
|
Indexed keywords
LEUKOTRIENE B4 RECEPTOR ANTAGONIST;
MYELOPEROXIDASE;
RP 517;
RP 517 TECHNETIUM TC 99M;
TECHNETIUM 99M;
TECHNETIUM DERIVATIVE;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DOG;
DRUG BINDING;
DRUG UPTAKE;
FLUORESCENCE ACTIVATED CELL SORTING;
HEART INFARCTION;
HEART MUSCLE REPERFUSION;
HUMAN;
HUMAN CELL;
MYOCARDITIS;
NEUTROPHIL;
NONHUMAN;
PRIORITY JOURNAL;
ANIMALS;
AUTORADIOGRAPHY;
BINDING, COMPETITIVE;
CORONARY CIRCULATION;
CORONARY DISEASE;
DOGS;
DRUG ADMINISTRATION ROUTES;
FLOW CYTOMETRY;
HEMODYNAMIC PROCESSES;
HUMANS;
INFLAMMATION;
INJECTIONS;
INJECTIONS, INTRAVENOUS;
MYOCARDIAL REPERFUSION;
MYOCARDITIS;
MYOCARDIUM;
NEUTROPHILS;
ORGANOTECHNETIUM COMPOUNDS;
PEROXIDASE;
PREDICTIVE VALUE OF TESTS;
RECEPTORS, LEUKOTRIENE B4;
REPERFUSION INJURY;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0037199472
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.0000023878.04716.6D Document Type: Article |
Times cited : (22)
|
References (25)
|